Valvular Heart Disease in Women Registry
Recruiting
Observational Study
Valve Disease, Heart
Gender Bias
Guideline Adherence
Guideline Implementation
Disparities
Registry
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 800 (estimated)
- Sponsor
- Valvular Heart Disease in Women Registry · Research network
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Valvular heart disease (VHD) is a major global health issue. Untreated rheumatic heart disease persists in many regions, preventable with timely care. Higher-income countries face rising calcific valve disease from aging, worsened by VHD complications, like infective endocarditis, resulting in higher morbidity/mortality. Gender disparities in VHD remains understudied, despite inequalities in risks…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients with diagnosis of any VHD according to the current ESC guidelines.
* Admission to the VHD-W Registry collaborating center.
Exclusion Criteria:
* Age less than 18 years old.
* Inability to provide informed consent per local institutional and regulatory requirem…
Contacts